Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer.

Westaby, Daniel; Jimenez-Vacas, Juan M; Padilha, Ana; Varkaris, Andreas; Balk, Steven P; de Bono, Johann S; Sharp, Adam

Westaby, Daniel; Jimenez-Vacas, Juan M; Padilha, Ana; Varkaris, Andreas; Balk, Steven P; de Bono, Johann S; Sharp, Adam.

Afiliación

Westaby D; Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK.
Jimenez-Vacas JM; Prostate Cancer Targeted Therapy Group, The Royal Marsden Hospital, London SM2 5PT, UK.
Padilha A; Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK.
Varkaris A; Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK.
Balk SP; Hematology-Oncology Division, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
de Bono JS; Hematology-Oncology Division, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Sharp A; Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK.

Cancers (Basel) ; 14(1)2021 Dec 23.

Article en En | MEDLINE | ID: mdl-35008216

Palabras clave

BH3 mimetics; apoptosis; cell death; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google